# Cardiovascular Diseases trials: 541 new since Nov 2024

Updated November 5, 2026.

541 clinical studies in Cardiovascular Diseases were first posted on ClinicalTrials.gov from November 12, 2024 to November 5, 2026; 74 have an industry sponsor and 376 are recruiting or about to. The newest, NCT07918846, was posted on November 5, 2026: A Clinical Study Testing Enicepatide in Participants Living With Overweight or Obesity and Cardiovascular... (Hoffmann-La Roche).

## The full list

New Cardiovascular Diseases clinical trials: 541 rows for $27.05, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 20 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/condition/cardiovascular-diseases

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 541
- Industry sponsored: 74
- Recruiting or not yet: 376
- Latest posted: November 5, 2026

## Newest trials

The newest 100 of 541, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 5, 2026 | NCT07918846 | A Clinical Study Testing Enicepatide in Participants Living With Overweight or Obesity and Cardiovascular Disease | Hoffmann-La Roche | Phase 3 | Not yet recruiting | Overweight, Obesity, Cardiovascular Disease | 8,200 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07918846) |
| November 4, 2026 | NCT07916883 | PET-MR Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Multisite) | Washington University School of Medicine | Observational | Not yet recruiting | Carotid Atherosclerosis, Carotid Artery Stenosis Asymptomatic, Asymptomatic Carotid Artery Stenosis | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916883) |
| November 3, 2026 | NCT07913607 | Real-World Validation of A Minimally Disruptive Ambulatory Blood Pressure Monitoring (ABPM) Huawei Smartwatch in Malaysia | Sunway University | Observational | Enrolling by invitation | Hypertension, Vascular Disease, Cardiovascular (CV) Risk, Cardiovascular Disease | 500 | Malaysia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913607) |
| November 3, 2026 | NCT07912320 | Long-Term Clinical, Health Economic, and Process Evaluation of Intensive Technology-Integrated Motor Rehabilitation in Chronic Neurological... | KU Leuven | Not applicable | Enrolling by invitation | Stroke, Spinal Cord Injuries (SCI), Chronic Disease | 100 | Belgium | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912320) |
| November 2, 2026 | NCT07911033 | Relationship Between Insulin Dose and Complications in Type 1 Diabetes | Rachel Miller | Observational | Not yet recruiting | Diabetes Mellitus, Type 1 Diabetes, Cardiovascular Diseases (CVD), Severe Albuminuria, Estimated Glomerular Filtration... | 80 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911033) |
| November 2, 2026 | NCT07910812 | Impact of a Tailored Digital Intervention on Sedentary Behaviour and Physical Health in Long-term Cardiac Rehabilitation Patients | University of Lisbon | Not applicable | Recruiting | Cardiovascular Diseases (CVD), Coronary Disease, Heart Failure, Cardiac Rehabilitation, Sedentary Behaviour | 64 | Portugal | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07910812) |
| November 2, 2026 | NCT07909395 | Cardiovascular Disease Multimorbidity | NYU Langone Health | Not applicable | Not yet recruiting | Cardiovascular Diseases | 1,050 | Nigeria, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909395) |
| November 2, 2026 | NCT07908810 | Threshold-Based Versus Range-Based Exercise Intensity Prescription in Cardiac Rehabilitation | Hasselt University | Not applicable | Not yet recruiting | Cardiovascular Diseases, Cardiac Rehabilitation | 230 | Belgium | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07908810) |
| October 28, 2026 | NCT07900633 | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 3,000 | Argentina, Australia, Brazil, Canada, China, Czechia, France, Germany, Hungary... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900633) |
| October 23, 2026 | NCT07892664 | Reducing Arterial Inflammation Using Eplerenone and Statins in HIV | Massachusetts General Hospital | Phase 2/3 | Not yet recruiting | HIV (Human Immunodeficiency Virus), Cardiovascular Diseases (CVD), Arterial Inflammation, Heart Disease | 124 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07892664) |
| October 23, 2026 | NCT07891052 | Wearable Ultrasound for Cardiac Monitoring During Surgery and in Intensive Care | China National Center for Cardiovascular Diseases | Not applicable | Not yet recruiting | Cardiovascular Diseases | 600 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07891052) |
| October 21, 2026 | NCT07884903 | Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks | Shanxi Bethune Hospital | Observational | Not yet recruiting | Obesity & Overweight, Diabetes Mellitus, Type 2, Hypertension, Non-alcoholic Fatty Liver Disease (MASLD)... | 25,974 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07884903) |
| October 19, 2026 | NCT07881250 | EValuation of prognostIc and Cost reDuction by tElemonitoring iN CIEDs Usual carE: an Updated Analysis Using 2019-2023 Data | Implicity | Observational | Active not recruiting | Cardiovascular Diseases (CVD), Cardiac Implantable Electronic Device (CIED) | 100,000 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881250) |
| October 16, 2026 | NCT07879144 | Digital Nudges to Improve Heart Health Actions After Community Screening in Malaysia (NADI-MyHeartRisk) | Cardiovascular Advancement and Research Excellence Institute | Not applicable | Not yet recruiting | Cardiovascular Diseases, Cardiovascular Risk Factor | 6,588 | Malaysia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07879144) |
| October 16, 2026 | NCT07878520 | Effectiveness of the "Aktivplan" Digital Intervention for Supporting Regular Heart-Healthy Physical Activity Following Phase II Cardiac... | Salzburg Research Forschungsgesellschaft mbH | Not applicable | Not yet recruiting | Cardiovascular Diseases (CVD) | 68 | Austria | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07878520) |
| October 16, 2026 | NCT07878325 | Effects of a Specialized Diabetes and Heart Clinic and Detection of Unrecognized Heart Failure in People With Type 2 Diabetes and... | Odense University Hospital | Not applicable | Recruiting | Cardiovascular Disease, Cardiometabolic Diseases, Diabetes Type 2, Diabetes and Heart Failure, Heart Failure With... | 375 | Denmark | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07878325) |
| October 13, 2026 | NCT07872358 | Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCl25 mg/5 mg/1000 mg Extended Release Tablet Versus Trijardy® XR 25... | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Type 2 Diabetes Mellitus (T2DM), Cardiovascular Diseases | 36 | India | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07872358) |
| October 13, 2026 | NCT07872046 | A Study on the Impact of Recombinant Zoster Vaccine on Major Adverse Cardiovascular Events in Adults \>=50 Years of Age With Established... | GlaxoSmithKline | Phase 3 | Not yet recruiting | Cardiovascular Disease | 16,390 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07872046) |
| October 13, 2026 | NCT07870941 | A Study on Abnormal Menstrual Bleeding in Chinese Women of Childbearing Age Taking Antithrombotic Drugs After Cardiovascular Surgery | Shanghai Zhongshan Hospital | Observational | Recruiting | Uterine Hemorrhage, Cardiovascular Diseases, Antithrombotic Drugs | 1,308 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07870941) |
| October 9, 2026 | NCT07869069 | Advancing Health Equity and Preventive Cardiovascular Care in Indigenous and Remote Communities: a Mobile Healthcare Unit | Laval University | Not applicable | Recruiting | Cardiovascular (CV) Risk, Metabolic Health, Primary Prevention | 500 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869069) |
| October 8, 2026 | NCT07865936 | Cardiovascular Risk Assessment and Coronary Calcium Score in Thai MASLD Patients | Watcharasak Chotiyaputta | Observational | Recruiting | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Cardiovascular Disease (CVD), Coronary Artery... | 251 | Thailand | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07865936) |
| October 7, 2026 | NCT07864259 | Cardiovascular History and Hemodynamic Complications After Intubation in ICU | University Hospital, Strasbourg, France | Observational | Recruiting | Hemodynamic Complications | 160 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07864259) |
| October 7, 2026 | NCT07863674 | Cardiovascular Risk Factors in Mexican Women | Medicaweb, S.A.C.V. | Observational | Not yet recruiting | Cardiovascular Risk Factors, Cardiovascular Diseases | 3,000 | Mexico | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07863674) |
| October 6, 2026 | NCT07859709 | The CLASP III TR CED Study | Edwards Lifesciences | Observational | Not yet recruiting | Tricuspid Regurgitation, Heart Valve Diseases, Heart Diseases, Cardiovascular Diseases, Tricuspid Valve Insufficiency | 2,350 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07859709) |
| October 2, 2026 | NCT07856667 | COINCIDE: Cardineurovascular dIsease and Obstructive Airway Disease | VASCage GmbH | Observational | Not yet recruiting | Chronic Obstructive Pulmonary Disease (COPD), Severe Asthma, Cardiovascular Diseases | 350 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07856667) |
| October 2, 2026 | NCT07856472 | AI-Powered Electrocardiography for Diagnosis and Prognostic Prediction in Cardiovascular Disease (AI-CVD): Multicenter Retrospective Study | Inha University Hospital | Observational | Recruiting | Cardiovascular Diseases, Coronary Artery Disease, Heart Failure, Atrial Fibrillation (AF), Ventricular Hypertrophy | 10,000 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07856472) |
| October 2, 2026 | NCT07854808 | Trial Without Borders IMPLEMENT-CKD: IMPLEMENTation of Evidence-Based SGLT2i to Reduce Global Burden of Cardiovascular and Chronic Kidney... | The University of Queensland | Observational | Not yet recruiting | Implementation Research, Kidney Disease, Cardiovascular Disease, Chronic Illness | 1,390 | Fiji, Samoa, Thailand | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07854808) |
| September 30, 2026 | NCT07849595 | Monitoring Blood Pressure at Home and Pharmacy Telehealth Among People Living With HIV | University of Alabama at Birmingham | Not applicable | Not yet recruiting | Hypertension, Blood Pressure Monitoring | 572 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07849595) |
| September 30, 2026 | NCT07849127 | wCAR-Austria: A Women-Specific Score to Assess Cardiovascular Risk in Women Aged 40 to 65 | Women's Heart Austria | Not applicable | Not yet recruiting | Cardiovascular Diseases (CVD), Coronary Artery Disease, Atheroscleroses | 800 | Austria | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07849127) |
| September 29, 2026 | NCT07847970 | VITAL: Real-World Evaluation of Amlodipine/Valsartan. | VIVA PHARM LLP | Observational | Active not recruiting | Hypertension, Cardiovascular Diseases (CVD) | 216 | Kazakhstan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07847970) |
| September 29, 2026 | NCT07847112 | Soluble TREM-1 in Diabetes-Associated Cardiovascular Complications | Assiut University | Observational | Not yet recruiting | Type 2 Diabetes Mellitus, Cardiovascular Diseases, Coronary Artery Disease, Heart Failure, Arrhythmias, Arrhythmias... | 85 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07847112) |
| September 28, 2026 | NCT07843472 | A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established... | Hoffmann-La Roche | Phase 3 | Recruiting | Obesity or Overweight, Cardiovascular Disease | 2,500 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07843472) |
| September 25, 2026 | NCT07843004 | Capitalizing on AI to CapTure Undiagnosed Structural Heart Disease | Pierre Elias | Not applicable | Active not recruiting | Structural Heart Abnormality, Valve Heart Disease, Heart Diseases, Cardiovascular Diseases | 4,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07843004) |
| September 24, 2026 | NCT07839936 | A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular Disease | Verve Therapeutics, Inc. | Phase 2 | Not yet recruiting | Atherosclerosis, Cardiovascular Disease, Hypercholesterolemia | 175 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07839936) |
| September 24, 2026 | NCT07839429 | Effect of mHealth Intervention on Oral Health-Related Quality of Life Among Adult Patients With Chronic Systemic Diseases | King Faisal University | Not applicable | Completed | Hereditary Blood Disorders, Cardiovascular Diseases, Chronic Kidney Disease, Diabete Mellitus | 206 | Saudi Arabia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07839429) |
| September 24, 2026 | NCT07838649 | Positron Emission Tomography (PET) Imaging of Chemotherapy-Induced Cardiotoxicity | Washington University School of Medicine | Phase 1 | Not yet recruiting | Lymphoma Cancer, Breast Cancer, Cancer of the Breast, Non-Hodgkin Lymphoma, Hodgkin Lymphoma | 36 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07838649) |
| September 24, 2026 | NCT07837934 | Colchicine for Primary Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes | Tan Tock Seng Hospital | Phase 2 | Recruiting | Type 2 Diabetes Mellitus (T2DM), Atherosclerosis, Cardiovascular Diseases | 300 | Singapore | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07837934) |
| September 23, 2026 | NCT07835828 | Optimised Cardiovascular and Renal Protection in Patients With Chronic Kidney Disease and Cardiovascular Disease | Odense University Hospital | Not applicable | Recruiting | Chronic Kidney Disease, Heart Failure With Preserved Ejection Fraction (HFPEF), Cardiovascular Diseases | 500 | Denmark | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07835828) |
| September 22, 2026 | NCT07835282 | Germany on Target Registry | Deutsche Gesellschaft für Lipidologie e. V. (DGFL) - Lipid-Liga | Observational | Not yet recruiting | Myocardial Infarction (MI), Dyslipidemias | 10,000 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07835282) |
| September 21, 2026 | NCT07829380 | The Cardiovascular-Cognitive Health Initiative | National Heart Centre Singapore | Not applicable | Recruiting | Cognitive Impairment | 5,000 | Singapore | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07829380) |
| September 21, 2026 | NCT07829341 | Qungasvik (Toolbox)-Healthy Hearts: A Cultural Approach to Reducing Chronic Disease Risk | University of Alaska Fairbanks | Not applicable | Not yet recruiting | Cardio Vascular Disease, Cerebro Vascular Disease, Mental Health, Chronic Disease (Physical) | 300 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07829341) |
| September 17, 2026 | NCT07825246 | Development and Clinical Validation of a Smart Analysis System for a Wearable Cardiac Ultrasound Device | Kunjing Pang | Not applicable | Not yet recruiting | Cardiovascular Diseases | 600 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07825246) |
| September 16, 2026 | NCT07822022 | Implementing Improved Blood Pressure Measurement in General Practice: A Multisite Implementation Trial Using Automated Office Blood... | Menzies Institute for Medical Research | Not applicable | Not yet recruiting | Hypertension, Cardiovascular Diseases (CVD), Vascular Diseases | 6,000 | Australia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07822022) |
| September 14, 2026 | NCT07817667 | Epicardial Fat Immunity extRa Cellular vesicleS HearT | Assistance Publique Hopitaux De Marseille | Not applicable | Not yet recruiting | Cardiac Surgery | 100 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07817667) |
| September 14, 2026 | NCT07817576 | Serial Biomarker Testing and Cardiovascular Risk Stratification (ACHILLES) | University Hospital Freiburg | Observational | Active not recruiting | Heart Failure, ASCVD, CKD | 110,000 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07817576) |
| September 14, 2026 | NCT07817290 | Development of Smart Food /Nutraceutical Solutions Dedicated to Cardiometabolic Disorders in Ageing | Azienda Ospedaliero Universitaria Maggiore della Carita | Not applicable | Recruiting | Prediabetes | 15 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07817290) |
| September 11, 2026 | NCT07816185 | A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier) | Pulmovant, Inc. | Phase 3 | Recruiting | Pulmonary Hypertension, Interstitial Lung Disease, Vascular Diseases, Cardiovascular Diseases, Fibrosis | 376 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07816185) |
| September 3, 2026 | NCT07803120 | Effects of External Upper Limb Loading on Gait and Trunk Muscle Activity in Cardiac Rehabilitation Patients | Pomeranian University in Slupsk | Observational | Active not recruiting | Cardiovascular Diseases, Cardiac Rehabilitation, Gait Abnormality, Muscle Contraction, Exercise Tolerance | 60 | Poland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07803120) |
| September 3, 2026 | NCT07802457 | Diagnosis of Women With ANOCA | NHS Greater Glasgow and Clyde | Observational | Not yet recruiting | Angina With No Obstructive Coronary Artery Disease | 400 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07802457) |
| September 2, 2026 | NCT07800481 | PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Volunteer - Dosimetry Study) | Washington University School of Medicine | Early phase 1 | Recruiting | Healthy Adult, Healthy | 8 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07800481) |
| September 1, 2026 | NCT07796217 | Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy | Seoul National University Bundang Hospital | Phase 4 | Recruiting | Cardiac Event, Coronary Artery Disease, Peripheral Artery Disease, Bleeding | 2,758 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07796217) |
| August 31, 2026 | NCT07793747 | Serum Asprosin, Metabolic Syndrome, and Cardiometabolic Risk in Rheumatoid Arthritis | Assiut University | Observational | Not yet recruiting | Rheumatoid Arthritis, Metabolic Syndrome, Cardiovascular Diseases | 75 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07793747) |
| August 28, 2026 | NCT07792005 | Sacha Inchi-CoQ10 Supplementation and Cardiovascular Health | Hospital Pengajar Universiti Putra Malaysia | Not applicable | Not yet recruiting | Cardiovascular Disease (CVD), Elevated Cardiovascular Risk, Endothelial Dysfunction | 60 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07792005) |
| August 26, 2026 | NCT07788040 | Intracardiac Echocardiography Catheter Supply-Chain Reliability and Clinical Access Study | Truway Health, Inc. | Observational | Enrolling by invitation | Cardiovascular Diseases, Arrhythmias, Cardiac, Atrial Fibrillation | 200 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07788040) |
| August 25, 2026 | NCT07785921 | Health Behaviour and Readiness to Change After Myocardial Infarction: A Cross-sectional Survey | Kliniken Essen-Mitte | Observational | Not yet recruiting | Cardiovascular (CV) Risk, Heart Attack Patients | 143 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07785921) |
| August 25, 2026 | NCT07785518 | Prevalenza Della Insulino Resistenza e Correlate Malattie Cardiovascolari Nella città di Napoli | Comune di Napoli | Observational | Completed | Insulin Resistance Syndrome, Cardio Vascular Disease, Prevalence | 123,752 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07785518) |
| August 25, 2026 | NCT07785388 | Genistein for the Reduction of Adverse Cardiovascular Events (GRACE) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Phase 1/2 | Not yet recruiting | HIV, Vascular Disease, Inflammation, Pain Management | 60 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07785388) |
| August 25, 2026 | NCT07783802 | A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event | Eli Lilly and Company | Phase 2 | Recruiting | Atherosclerosis, Cardiovascular Disease, Obesity, Hypertension, Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic | 120 | Argentina, Japan, Puerto Rico, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07783802) |
| August 24, 2026 | NCT07781371 | A Retrospective Real-World Cohort Study | Novo Nordisk A/S | Observational | Active not recruiting | Obesity, Type 2 Diabetes (T2D), Prediabetes, Cardiovascular Disease (CVD), Dyslipidemia, Metabolic... | 100,000 | Denmark | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07781371) |
| August 21, 2026 | NCT07780552 | CHIP in Health and Disease | VASCage GmbH | Observational | Not yet recruiting | Clonal Hematopoiesis, Clonal Hematopoiesis of Indeterminate Potential, Clonal Cytopenia of Undetermined Significance... | 120 | Austria | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07780552) |
| August 21, 2026 | NCT07780500 | REFOCUS-HTN US-WEST: A Data Infrastructure to Characterize Individuals With Hypertension | Kaiser Permanente | Observational | Recruiting | Hypertension, Aldosterone Disorder, Cardiovascular Disease (CVD) | 500 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07780500) |
| August 20, 2026 | NCT07775976 | Cor360: Clinician-Facing Broad-Spectrum Cardiac Phenotyping and Risk Assessment Using COR® Wearable ECG to Inform Outcomes-Oriented Care... | Peerbridge Health, Inc | Observational | Enrolling by invitation | Cardiovascular Diseases, Cardiovascular Diseases Risk, Cardiac Conduction System Disease, Bundle/Fascicular... | 1,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775976) |
| August 18, 2026 | NCT07770737 | Cardioprotective Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Korean Patients With Type 2 Diabetes | Dongtan Sacred Heart Hospital | Observational | Not yet recruiting | Type 2 Diabetes Mellitus (T2DM), Cardiovascular Diseases, Stage B Heart Failure | 100 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07770737) |
| August 17, 2026 | NCT07769190 | Cardiovascular Mortality Prediction in Maintenance Hemodialysis Patients | Huashan Hospital | Observational | Completed | End-Stage Kidney Disease (ESKD), Cardiovascular Disease, Secondary Hyperparathyroidism (SHPT) | 192 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07769190) |
| August 13, 2026 | NCT07763340 | Photon-Counting Cardiac CT in Post-PCI Patients | Chinese PLA General Hospital | Observational | Recruiting | Cardiovascular Diseases | 800 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07763340) |
| August 6, 2026 | NCT07748858 | Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities | University of Alabama at Birmingham | Observational | Recruiting | Cardiovascular, Comorbidity, Diabetes, Inflammatory Joint Diseases, Chronic Kidney Diease, Chronic Obstructive... | 29 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07748858) |
| August 5, 2026 | NCT07746310 | Dietary Nitrate and Nitrite Intake and Phosphate Biomarkers and Risk of Chronic Diseases | Karolinska Institutet | Observational | Completed | Healthy, Gastrointestinal Cancer, Cardiovascular Diseases, Chronic Obstructive Airway Disease, Asthma (Diagnosis) | 86,000 | Sweden | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07746310) |
| August 3, 2026 | NCT07743021 | Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data | Center for Molecular Fingerprinting Research Nonprofit LLC | Observational | Recruiting | Non-communicable Diseases (NCD), Neoplams, Cancer, Lung Cancer (NSCLC), Cardiovascular Diseases (CVD), Atherosclerotic... | 15,000 | Hungary | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07743021) |
| August 3, 2026 | NCT07741955 | Empowering Veterans in Research Effectively Using Virtual Engagement Tools | VA Office of Research and Development | Not applicable | Not yet recruiting | Atrial Fibrillation (AF), Cardiovascular Diseases | 100,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07741955) |
| July 31, 2026 | NCT07738250 | Routine LDL Exam For Cancer Survivors | Samsung Medical Center | Observational | Completed | Cancer Survivorship, Cardiovascular Disease | 1,294,726 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07738250) |
| July 30, 2026 | NCT07735689 | Evaluate the Value of Modified Shock Index in Predicting the Incidence of Cardiovascular Events After Non-cardiac Surgery in Cardiac... | Fujian Medical University Union Hospital | Observational | Not yet recruiting | Cardiovascular Diseases (CVD), Postoperative | 1,500 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07735689) |
| July 29, 2026 | NCT07734948 | Cardiovascular Effects of Purple-Fleshed Potatoes | Instituto de Investigacion Nutricional, Peru | Not applicable | Not yet recruiting | PRE-HYPERTENSION | 300 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07734948) |
| July 29, 2026 | NCT07733986 | Exercise Therapy for Women With ANOCA | NHS Greater Glasgow and Clyde | Not applicable | Not yet recruiting | Angina Patients With Non-obstructive Coronary Artery Disease | 76 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07733986) |
| July 28, 2026 | NCT07730385 | Fish Oil and HDL Function in Patients on Maintenance Hemodialysis | Medical University of Vienna | Not applicable | Not yet recruiting | Kidney Failure Chronic, Cardiovascular Disease, HDL Cholesterol | 40 | Austria | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07730385) |
| July 27, 2026 | NCT07727135 | Rapid or Ultra-rapid Diagnosis of Myocardial Infarction Using High-Sensitivity Cardiac Troponin on Hospital Presentation | Herlev and Gentofte Hospital | Not applicable | Not yet recruiting | Coronary Syndrome, Acute, Myocardial Infarction, Coronary Artery Disease, Cardiovascular Diseases, Cardiovascular... | 28,000 | Denmark | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07727135) |
| July 24, 2026 | NCT07724522 | Prebiotic Inulin for Late-Reproductive Individuals | George Washington University | Not applicable | Recruiting | Obesity & Overweight, Perimenopausal Women, Prebiotics, Inulin, Muscle, Skeletal, Cardiovascular Diseases (CVD)... | 27 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07724522) |
| July 23, 2026 | NCT07723274 | A Physical Activity Programme Focussed on Step Volume and Intensity for People With Cardiovascular Disease: Getting Active and Staying... | Radboud University Medical Center | Not applicable | Not yet recruiting | Coronary Artery Disease | 334 | Netherlands | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07723274) |
| July 23, 2026 | NCT07721649 | Intrahospital Influenza Vaccination in Patients at High Cardiovascular Risk (VACC-UP) | Stephan Baldus | Not applicable | Recruiting | Acute Coronary Syndrome, Heart Failure, Influenza, Human, Cardiovascular Diseases, Vaccination Refusal | 482 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07721649) |
| July 23, 2026 | NCT07721584 | HeartMate App-Based Remote Monitoring for Cardiovascular Risk Factor Management | Yonsei University | Not applicable | Not yet recruiting | Cardiovascular Diseases, Heart Failure, Systolic, Coronary Artery Disease, Heart Valve Diseases, Peripheral Arterial... | 200 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07721584) |
| July 23, 2026 | NCT07721428 | Salivary Angiotensin-Converting Enzyme and Periodontal Disease in Cardiovascular Disease | Suleyman Demirel University | Observational | Completed | Periodontal Disease, Cardiovascular Disease | 76 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07721428) |
| July 22, 2026 | NCT07719439 | Heart Rate Variability and Early Cytokine Profile in Pediatric Adenotonsillectomy | Duzce University | Observational | Active not recruiting | Heart Rate Monitoring, Vagal Bradycardia, Adenotonsillar Hypertrophy, Tonsillitis; Hypertrophic, Adverse Cardiac Event... | 76 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07719439) |
| July 22, 2026 | NCT07718789 | Cardiovascular-Kidney-Metabolic Syndrome Registry | Centre for Chronic Disease Control, India | Observational | Not yet recruiting | Cardiovascular Kidney Metabolic Syndrome | 2,250 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07718789) |
| July 21, 2026 | NCT07717723 | Supporting Mental Health and Reducing Care Stress in Caregivers of Persons With Cardiovascular Disease | University of California, Davis | Not applicable | Recruiting | Caregiver Burden, Stress, Depression, Anxiety, Cardiovascular Diseases | 40 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07717723) |
| July 20, 2026 | NCT07714096 | Cardiometabolic & Cognitive Effects of Peanut Butter in Prediabetes | Penn State University | Not applicable | Not yet recruiting | Prediabetes | 56 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07714096) |
| July 17, 2026 | NCT07712380 | A Study Exploring the Effect of Adjuvanted RZV or RSVPreF3 Vaccines on Coronary Plaque Progression in Adults \>=50 Years of Age at Risk for... | GlaxoSmithKline | Phase 2 | Not yet recruiting | Cardiovascular Disease | 450 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07712380) |
| July 16, 2026 | NCT07707479 | Cardiovascular Effects of Parathyroid Hormone Analogues in Chronic Hypoparathyroidism | National and Kapodistrian University of Athens | Observational | Active not recruiting | Chronic Hypoparathyroidism | 210 | Greece | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07707479) |
| July 15, 2026 | NCT07704164 | Colchicine to Reduce Coronary Artery Inflammation in People With HIV | Instituto de Investigación Hospital Universitario La Paz | Phase 2 | Recruiting | HIV Infection, Cardiovascular Diseases (CVD) | 90 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07704164) |
| July 13, 2026 | NCT07697833 | Comparing the Efficacy and Safety of Vericiguat With Standard Medical Treatment in Heart Failure Patients | National Institute of Cardiovascular Diseases, Pakistan | Phase 4 | Not yet recruiting | Heart Failure With Reduced Ejection Fraction (HFrEF) | 500 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07697833) |
| July 9, 2026 | NCT07693712 | Senescence in Myocardial Infarction | South Tees Hospitals NHS Foundation Trust | Observational | Terminated | Cardiovascular Diseases, Coronary Artery Disease, Aging, Atherosclerosis, Myocardial Infarction, Inflammation, Heart... | 22 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07693712) |
| July 9, 2026 | NCT07692594 | Heart and Blood Vessels Health in People With Cystic Fibrosis | Liverpool Heart and Chest Hospital NHS Foundation Trust | Observational | Not yet recruiting | Cystic Fibrosis (CF), Cardiovascular (CV) Risk, Flow-mediated Dilation Evaluation of the Brachial Artery, Pulse Wave... | 32 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07692594) |
| July 9, 2026 | NCT07692191 | Transcutaneous Spinal Electrical Stimulation to Improve Exercise Function After Spinal Cord Injury. | University of Manitoba | Not applicable | Recruiting | Spinal Cord Injuries (SCI), Spinal Cord Injury, Spinal Injury | 40 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07692191) |
| July 8, 2026 | NCT07691203 | Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCl 25 mg/5 mg/1000 mg Extended Release Tablet Versus Trijardy® XR 25... | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Type 2 Diabetes Mellitus (T2DM), Cardiovascular Diseases | 36 | India | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07691203) |
| July 8, 2026 | NCT07689422 | The Effect of Web-Based Gamification Applications on Nursing Students' Learning Regarding Cardiopulmonary Resuscitation | Karadeniz Technical University | Not applicable | Completed | Cardiovascular Diseases, Cardiopulmonary Arrest, Web-based Gamification | 86 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07689422) |
| July 7, 2026 | NCT07687485 | Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System | Laplace Interventional, Inc | Not applicable | Recruiting | Severe Tricuspid Valve Regurgitation, Tricuspid Valve Regurgitation, Tricuspid Valve Disease, Cardiovascular Diseases... | 700 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07687485) |
| July 7, 2026 | NCT07686991 | Cardiovascular Risk in Patients With Takayasu Arteritis: A Nationwide Population-Based Cohort Study | Groupe français d'étude des Maladies Inflammatoires de loeil | Observational | Completed | Takayasu Arteritis, Cardiovascular Diseases | 8,275 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07686991) |
| July 6, 2026 | NCT07685938 | Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease | UNC Lineberger Comprehensive Cancer Center | Phase 2 | Recruiting | Chest Wall Tumor, Breast Cancer, Lung Cancer, Esophageal Cancer, Mediastinal Cancers, Spine Metastases, Spinal Tumor... | 60 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07685938) |
| July 6, 2026 | NCT07684313 | TRIFORMIS RESILIA Real-world Study Assessing Safety and Performance (TRIBLAZE Study) | Edwards Lifesciences | Observational | Recruiting | Heart Valve Diseases, Heart Diseases, Cardiovascular Diseases, Tricuspid Valve Disease | 75 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07684313) |
| July 2, 2026 | NCT07681180 | Evaluation of Anxiety Reduction in the Cathlab by Means of Pharmacological and Non-pharmacological Strategies | Olivier F. Bertrand | Not applicable | Not yet recruiting | Cardiovascular Disease, Cardiovascular Care, Pain and Anxiety During Cardiac Catheterization | 60 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07681180) |
| July 1, 2026 | NCT07679828 | Polypills Approach for Multiple Cardiovascular Risk Factors | China Medical University, China | Not applicable | Recruiting | Hypertension, Dyslipidemia, Diabetes | 8,252 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07679828) |
| July 1, 2026 | NCT07679763 | Randomized Cross-Over Comparison of Medium Cut-Off and High-Flux Hemodialysis Membranes | Gazi University | Not applicable | Active not recruiting | End Stage Kidney Disease (ESKD), Hemodialysis, Cardiovascular Diseases (CVD), Inflammation | 30 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07679763) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| Novartis Pharmaceuticals | 6 | April 22, 2026 |
| University of Alabama at Birmingham | 5 | September 30, 2026 |
| Karolinska Institutet | 5 | August 5, 2026 |
| National Medical Research Center for Therapy and Preventive Medicine | 5 | May 26, 2026 |
| Assiut University | 4 | September 29, 2026 |
| Penn State University | 4 | July 20, 2026 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 4 | September 23, 2025 |
| Medtronic Vascular | 4 | September 16, 2025 |
| Brigham and Women's Hospital | 4 | July 28, 2025 |
| University of California, San Francisco | 4 | July 25, 2025 |
| Washington University School of Medicine | 3 | November 4, 2026 |
| NYU Langone Health | 3 | November 2, 2026 |
| Eli Lilly and Company | 3 | October 28, 2026 |
| Massachusetts General Hospital | 3 | October 23, 2026 |
| Humanis Saglık Anonim Sirketi | 3 | October 13, 2026 |
| Shanghai Zhongshan Hospital | 3 | October 13, 2026 |
| Chinese PLA General Hospital | 3 | August 13, 2026 |
| VA Office of Research and Development | 3 | August 3, 2026 |
| Yonsei University | 3 | July 23, 2026 |
| Mayo Clinic | 3 | June 18, 2026 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 257 | November 3, 2026 |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 215 | November 4, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 17 | November 5, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 17 | September 24, 2026 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 17 | September 1, 2026 |
| [Phase 1](https://specstream.ai/data/clinical-trials/phase/phase-1) | 8 | October 13, 2026 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 5 | August 25, 2026 |
| [Early phase 1](https://specstream.ai/data/clinical-trials/phase/early-phase-1) | 3 | September 2, 2026 |
| [Phase 2/3](https://specstream.ai/data/clinical-trials/phase/phase-2-3) | 2 | October 23, 2026 |

## By country

| Country | New trials | Latest |
| --- | --- | --- |
| [United States](https://specstream.ai/data/clinical-trials/country/united-states) | 133 | November 4, 2026 |
| [China](https://specstream.ai/data/clinical-trials/country/china) | 63 | October 28, 2026 |
| [Italy](https://specstream.ai/data/clinical-trials/country/italy) | 34 | October 28, 2026 |
| [United Kingdom](https://specstream.ai/data/clinical-trials/country/united-kingdom) | 34 | September 3, 2026 |
| [Turkey (Türkiye)](https://specstream.ai/data/clinical-trials/country/turkey-t-rkiye) | 33 | October 28, 2026 |
| [Canada](https://specstream.ai/data/clinical-trials/country/canada) | 25 | October 28, 2026 |
| [France](https://specstream.ai/data/clinical-trials/country/france) | 25 | October 28, 2026 |
| [Spain](https://specstream.ai/data/clinical-trials/country/spain) | 25 | October 28, 2026 |
| [Germany](https://specstream.ai/data/clinical-trials/country/germany) | 23 | October 28, 2026 |
| [Denmark](https://specstream.ai/data/clinical-trials/country/denmark) | 22 | October 16, 2026 |
| [Netherlands](https://specstream.ai/data/clinical-trials/country/netherlands) | 18 | July 23, 2026 |
| [South Korea](https://specstream.ai/data/clinical-trials/country/south-korea) | 17 | October 28, 2026 |
| [Australia](https://specstream.ai/data/clinical-trials/country/australia) | 16 | October 28, 2026 |
| [Brazil](https://specstream.ai/data/clinical-trials/country/brazil) | 16 | October 28, 2026 |
| [Taiwan](https://specstream.ai/data/clinical-trials/country/taiwan) | 16 | May 11, 2026 |
| [Sweden](https://specstream.ai/data/clinical-trials/country/sweden) | 13 | August 5, 2026 |
| [India](https://specstream.ai/data/clinical-trials/country/india) | 11 | October 28, 2026 |
| [Japan](https://specstream.ai/data/clinical-trials/country/japan) | 11 | October 28, 2026 |
| [Poland](https://specstream.ai/data/clinical-trials/country/poland) | 11 | October 28, 2026 |
| [Russia](https://specstream.ai/data/clinical-trials/country/russia) | 11 | May 26, 2026 |
| [Greece](https://specstream.ai/data/clinical-trials/country/greece) | 10 | July 16, 2026 |
| [Portugal](https://specstream.ai/data/clinical-trials/country/portugal) | 9 | November 2, 2026 |
| [Argentina](https://specstream.ai/data/clinical-trials/country/argentina) | 9 | October 28, 2026 |
| [Czechia](https://specstream.ai/data/clinical-trials/country/czechia) | 9 | October 28, 2026 |
| [Switzerland](https://specstream.ai/data/clinical-trials/country/switzerland) | 9 | April 22, 2026 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).